Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2026-02-03 @ 10:12 AM
Study NCT ID:
NCT00678392
Status:
COMPLETED
Last Update Posted:
2019-01-09
First Post:
2008-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Sponsor:
Pfizer
Organization: